Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report)’s stock price fell 5.2% during trading on Thursday . The stock traded as low as $4.33 and last traded at $4.42. 632,491 shares were traded during trading, a decline of 28% from the average session volume of 875,832 shares. The stock had previously closed at $4.66.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on ACB. TD Cowen began coverage on shares of Aurora Cannabis in a research report on Wednesday, December 11th. They set a “buy” rating for the company. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th.
Get Our Latest Stock Report on Aurora Cannabis
Aurora Cannabis Stock Performance
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of ACB. Cubist Systematic Strategies LLC bought a new position in Aurora Cannabis in the second quarter valued at approximately $50,000. Toronto Dominion Bank lifted its stake in Aurora Cannabis by 34,356.4% in the second quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock valued at $88,000 after buying an additional 18,896 shares in the last quarter. Mackenzie Financial Corp bought a new position in Aurora Cannabis in the second quarter valued at approximately $113,000. Tidal Investments LLC lifted its stake in Aurora Cannabis by 2.7% in the third quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock valued at $7,905,000 after buying an additional 34,988 shares in the last quarter. Finally, Headlands Technologies LLC lifted its stake in Aurora Cannabis by 98.8% in the second quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock valued at $346,000 after buying an additional 37,269 shares in the last quarter. Institutional investors and hedge funds own 47.63% of the company’s stock.
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Recommended Stories
- Five stocks we like better than Aurora Cannabis
- Comparing and Trading High PE Ratio Stocks
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Stock Dividend Cuts Happen Are You Ready?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.